Monrovia Company Using AI to Create Therapeutic Drugs


Here is a New York Times article about the Monrovia company, Terray Therapeutics, which is using Artificial Intelligence (AI) to develop new drugs for inflammatory diseases such as lupus, psoriasis and rheumatoid arthritis. The company, located at 750 Royal Oaks Drive, hopes to have drugs in clinical trials by early 2026.

- Brad Haugaard 




No comments:

Post a Comment